Lisa Gill
Stock Analyst at JP Morgan
(0)
# 3628
Out of 5,291 analysts
146
Total ratings
50.62%
Success rate
-1.27%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Concentra Group Hold... | Maintains: Overweight | 29 30 | 21.48 | 39.66% | 2 | Mar 19, 2025 | |
Option Care Health | Maintains: Overweight | 40 41 | 34.7 | 18.16% | 4 | Mar 6, 2025 | |
Alignment Healthcare | Maintains: Neutral | 14 17 | 18.3 | -7.1% | 4 | Mar 6, 2025 | |
Humana | Maintains: Neutral | 257 256 | 264.02 | -3.04% | 6 | Feb 18, 2025 | |
CVS Health | Maintains: Overweight | 80 81 | 67.11 | 20.7% | 5 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 173 180 | 167.22 | 7.64% | 2 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 142 145 | 136.43 | 6.28% | 6 | Feb 4, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 289 301 | 275.2 | 9.38% | 2 | Jan 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 18 | 10.91 | 64.99% | 2 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 5 | 3.06 | 63.4% | 4 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 28 | 23.95 | 16.91% | 4 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 28 | 22.57 | 24.06% | 4 | Nov 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 15 | 11.19 | 34.05% | 14 | Aug 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 9 | 8.12 | 10.84% | 9 | Aug 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 22 18 | 8.59 | 109.55% | 4 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 656 661 | 668.25 | -1.08% | 10 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 435 438 | 324.98 | 34.78% | 9 | Aug 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 18 | 13.18 | 36.57% | 1 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 420 395 | 322.75 | 22.39% | 2 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 261 243 | 229.63 | 5.82% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 182 186 | 186.11 | -0.06% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 546 559 | 515.54 | 8.43% | 5 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 107 140 | 133.11 | 5.18% | 1 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 327 332 | 342.18 | -2.98% | 3 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 628 631 | 431.84 | 46.12% | 4 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 7 10 | 4.5 | 122.22% | 1 | Mar 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 9 | 4.48 | 100.89% | 3 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 8 | 6.72 | 19.05% | 4 | Nov 17, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 83 | 68.59 | 21.01% | 1 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 191 198 | n/a | n/a | 4 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 39 | n/a | n/a | 1 | Feb 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 103 98 | 59.95 | 63.47% | 1 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 41 28 | n/a | n/a | 2 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 21 12 | n/a | n/a | 4 | Jun 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 74 | n/a | n/a | 3 | Mar 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 26 24 | 31.21 | -23.1% | 4 | Jun 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Dec 19, 2017 |